Myelofibrosis and Essential Thrombocythemia Observational Study - Adventist HealthCare

Clinical Trial Details

MOST

Myelofibrosis and Essential Thrombocythemia Observational Study

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 12/01/2016
Study Completion Date: 12/31/2021

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

NCT Number
NCT02953704
Principal Investigator(s)
John Wallmark, MD
Sponsor(s)
Incyte Corporation
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.